These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11986952)
1. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO). Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952 [TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Hofmann BT; Jücker M Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814 [TBL] [Abstract][Full Text] [Related]
3. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409 [TBL] [Abstract][Full Text] [Related]
4. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways. Hsu JH; Shi Y; Frost P; Yan H; Hoang B; Sharma S; Gera J; Lichtenstein A Oncogene; 2004 Apr; 23(19):3368-75. PubMed ID: 15021914 [TBL] [Abstract][Full Text] [Related]
6. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells. Nieborowska-Skorska M; Slupianek A; Skorski T Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572 [TBL] [Abstract][Full Text] [Related]
7. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase. Ren SY; Xue F; Feng J; Skorski T Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545 [TBL] [Abstract][Full Text] [Related]
9. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway. Rong R; He Q; Liu Y; Sheikh MS; Huang Y Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823 [TBL] [Abstract][Full Text] [Related]
10. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Tan J; Hallahan DE Cancer Res; 2003 Nov; 63(22):7663-7. PubMed ID: 14633687 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504 [TBL] [Abstract][Full Text] [Related]
13. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
14. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis. Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Chen EY; Mazure NM; Cooper JA; Giaccia AJ Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities. Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538 [TBL] [Abstract][Full Text] [Related]
18. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases. Susa M; Rohner D; Bichsel S Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833 [TBL] [Abstract][Full Text] [Related]
19. Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. Yoon SO; Kim MM; Park SJ; Kim D; Chung J; Chung AS FASEB J; 2002 Jan; 16(1):111-3. PubMed ID: 11709494 [TBL] [Abstract][Full Text] [Related]
20. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]